These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34673273)

  • 1. Prostate cancer clinical trial completion: The role of geography.
    Stensland KD; Kaffenberger SD; George AK; Morgan TM; Miller DC; Salami SS; Dunn RL; Palapattu GS; Montgomery JS; Hollenbeck BK; Skolarus TA
    Contemp Clin Trials; 2021 Dec; 111():106600. PubMed ID: 34673273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
    Khunger M; Rakshit S; Hernandez AV; Pasupuleti V; Glass K; Galsky MD; Grivas P
    Oncologist; 2018 Dec; 23(12):1494-1499. PubMed ID: 30068783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Terminated Hand and Wrist-Related Clinical Trials.
    Delma S; Foster BK; Baylor JL; Ozdag Y; Manzar S; Langford K; Klena JC; Grandizio LC
    J Hand Surg Glob Online; 2023 Sep; 5(5):673-676. PubMed ID: 37790828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database.
    Cihoric N; Vlaskou Badra E; Tsikkinis A; Prasad V; Kroeze S; Igrutinovic I; Jeremic B; Beck M; Zschaeck S; Wust P; Ghadjar P
    Radiat Oncol; 2018 Jun; 13(1):113. PubMed ID: 29914515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of managed care on cancer trial enrollment.
    Gross CP; Krumholz HM
    J Clin Oncol; 2005 Jun; 23(16):3811-8. PubMed ID: 15923575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of premature termination of cardiac surgery trials: insights from the Clinicaltrial.gov database.
    Cancelli G; Rossi CS; Dell'Aquila M; Mantaj P; Hirofuji A; Soletti G; Harik L; Cangut B; Al Zaghari T; Leith J; Falco G; Ibrahim M; Dimagli A; Rahouma M; Gaudino MFL
    Eur J Cardiothorac Surg; 2024 Aug; 66(2):. PubMed ID: 39133169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.
    Allott EH; Markt SC; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Mucci LA; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):783-789. PubMed ID: 29669727
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence.
    Tran G; Harker M; Chiswell K; Unger JM; Fleury ME; Hirsch B; Miller K; d'Almada P; Tibbs S; Zafar SY
    JCO Clin Cancer Inform; 2020 Jan; 4():35-49. PubMed ID: 31977253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.
    de Koning HJ; Gulati R; Moss SM; Hugosson J; Pinsky PF; Berg CD; Auvinen A; Andriole GL; Roobol MJ; Crawford ED; Nelen V; Kwiatkowski M; Zappa M; Luján M; Villers A; de Carvalho TM; Feuer EJ; Tsodikov A; Mariotto AB; Heijnsdijk EAM; Etzioni R
    Cancer; 2018 Mar; 124(6):1197-1206. PubMed ID: 29211316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Termination of Urologic Cancer Clinical Trials: Insights and Challenges.
    Alhajahjeh A; Hmeidan M; Elatrsh M; Al-Abbadi F; Kakish D; Sukerji R; Salah M; Al Awamlh BAH; Lee DI; Shahait M
    JCO Glob Oncol; 2024 Jan; 10():e2300349. PubMed ID: 38207249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.
    Gaziano JM; Glynn RJ; Christen WG; Kurth T; Belanger C; MacFadyen J; Bubes V; Manson JE; Sesso HD; Buring JE
    JAMA; 2009 Jan; 301(1):52-62. PubMed ID: 19066368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer Incidence in U.S. Counties and Low Levels of Arsenic in Drinking Water.
    Ahn J; Boroje IJ; Ferdosi H; Kramer ZJ; Lamm SH
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033184
    [No Abstract]   [Full Text] [Related]  

  • 18. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
    Muralidhar V; Rose BS; Chen YW; Nezolosky MD; Nguyen PL
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):313-317. PubMed ID: 27496390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008.
    Alghamidi IG; Hussain II; Alghamdi MS; El-Sheemy MA
    Hematol Oncol Stem Cell Ther; 2014 Mar; 7(1):18-26. PubMed ID: 24239850
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.